MCL Clinical Trials
1230 trials from ClinicalTrials.gov. Recruiting trials shown first.
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
COMPLETEDNCT00014235·NA·Fred Hutchinson Cancer Center·160 enrolled
fludarabine phosphatetotal-body irradiationperipheral blood stem cell transplantationallogeneic hematopoietic stem cell transplantationcyclosporine+2 more
Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation
COMPLETEDNCT00014482·NA·Memorial Sloan Kettering Cancer Center
pain therapypsychosocial assessment and care
Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
UNKNOWNNCT00016887·PHASE3·German Low Grade Lymphoma Study Group
filgrastimrecombinant interferon alfacarmustinecyclophosphamidecytarabine+6 more
Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer
COMPLETEDNCT00010192·PHASE1·National Cancer Institute (NCI)·30 enrolled
rituximabaldesleukinlaboratory biomarker analysispharmacological study
ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma
COMPLETEDNCT00016172·PHASE1·Memorial Sloan Kettering Cancer Center
pegylated liposomal doxorubicin hydrochloridepicoplatin
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment
COMPLETEDNCT00398372·NA·Stanford University·500 enrolled
RituximabEpratuzumab
Monoclonal Antibody Therapy in Treating Patients With Recurrent or Refractory Lymphoma
COMPLETEDNCT00007956·PHASE1·National Cancer Institute (NCI)
monoclonal antibody mono-dgA-RFB4
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
COMPLETEDNCT00054327·PHASE2·Case Comprehensive Cancer Center·34 enrolled
busulfancyclophosphamidecytarabineradiation therapyEtoposide+1 more
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
COMPLETEDNCT00006747·PHASE2·Alliance for Clinical Trials in Oncology·4 enrolled
carmustinemelphalanetoposidecytarabinetacrolimus+3 more
BMS-247550 in Treating Patients With Advanced Cancers
COMPLETEDNCT00006221·PHASE1·National Cancer Institute (NCI)·54 enrolled
ixabepilone
Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation
COMPLETEDNCT00005946·PHASE1·University of Maryland, Baltimore
filgrastimtherapeutic allogeneic lymphocytescyclophosphamideetoposide
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
COMPLETEDNCT00006348·PHASE3·Alliance for Clinical Trials in Oncology·100 enrolled
ondansetronplacebo
Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
COMPLETEDNCT00005601·PHASE2·Alliance for Clinical Trials in Oncology·58 enrolled
rituximabcisplatincytarabinedexamethasonesargramostim
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
TERMINATEDNCT00014560·PHASE1·Dartmouth-Hitchcock Medical Center·3 enrolled
bispecific antibody 4G7xH22sargramostim
Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's Lymphoma
COMPLETEDNCT00007852·PHASE2·University of Nebraska·44 enrolled
rituximabcarmustinecytarabineetoposidemelphalan+1 more
Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
COMPLETEDNCT00007865·PHASE2·University of Nebraska
rituximabcarboplatinetoposideifosfamide
Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
COMPLETEDNCT00012207·PHASE1·Fred Hutchinson Cancer Center·12 enrolled
aldesleukintherapeutic autologous lymphocytescyclophosphamideprednisonevincristine sulfate+1 more
Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
COMPLETEDNCT00006473·PHASE2·National Cancer Institute (NCI)·72 enrolled
oxaliplatin
Tipifarnib in Treating Patients With Advanced Hematologic Cancer
COMPLETEDNCT00005967·PHASE1·National Cancer Institute (NCI)·36 enrolled
tipifarnib
Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma
TERMINATEDNCT00183989·PHASE2·University of Southern California·30 enrolled
Fludarabine, Mitoxantrone and Rituximab
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
COMPLETEDNCT00008359·PHASE3·Memorial Sloan Kettering Cancer Center
caspofungin acetateliposomal amphotericin B
Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors
COMPLETEDNCT00004157·PHASE2·Fred Hutchinson Cancer Center
filgrastimrecombinant interleukin-11
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
COMPLETEDNCT00010283·PHASE1 / PHASE2·Fred Hutchinson Cancer Center
beclomethasone dipropionate
Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma
COMPLETEDNCT00005780·PHASE2·National Cancer Institute (NCI)·26 enrolled
EPOCH-RGM-CSFIdiotype vaccine
Non-Ablative Allo HSCT For Hematologic Malignancies or SAA
COMPLETEDNCT00006379·PHASE2·Case Comprehensive Cancer Center·58 enrolled
anti-thymocyte globulingraft-versus-tumor induction therapycyclophosphamidefludarabine phosphateperipheral blood stem cell transplantation
Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma
COMPLETEDNCT00028665·PHASE2·Case Comprehensive Cancer Center·37 enrolled
filgrastimrituximabcarmustinecisplatincyclophosphamide+4 more
Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
COMPLETEDNCT00365287·PHASE1 / PHASE2·Masonic Cancer Center, University of Minnesota·148 enrolled
anti-thymocyte globulincyclophosphamidecyclosporinefludarabine phosphatemycophenolate mofetil+2 more
Phase 2 Hyper-CVAD/Rituximab for Untreated Mantle Cell Lymphoma
COMPLETEDNCT00581854·PHASE2·University of Wisconsin, Madison·22 enrolled
modified Hyper-CVAD
Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients
COMPLETEDNCT00562978·PHASE1 / PHASE2·City of Hope Medical Center·54 enrolled
filgrastimcyclophosphamideetoposideAHSCTyttrium Y 90 ibritumomab tiuxetan
Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma
COMPLETEDNCT00004192·PHASE2·University of Nebraska·60 enrolled
filgrastimpegfilgrastimcisplatincytarabineetoposide+1 more